Matches in SemOpenAlex for { <https://semopenalex.org/work/W2916895208> ?p ?o ?g. }
- W2916895208 endingPage "153303381983106" @default.
- W2916895208 startingPage "153303381983106" @default.
- W2916895208 abstract "T-cell receptor–engineered T-cell therapy and chimeric antigen receptor T-cell therapy are 2 types of adoptive T-cell therapy that genetically modify natural T cells to treat cancers. Although chimeric antigen receptor T-cell therapy has yielded remarkable efficacy for hematological malignancies of the B-cell lineages, most solid tumors fail to respond significantly to chimeric antigen receptor T cells. T-cell receptor–engineered T-cell therapy, on the other hand, has shown unprecedented promise in treating solid tumors and has attracted growing interest. In order to create an unbiased, comprehensive, and scientific report for this fast-moving field, we carefully analyzed all 84 clinical trials using T-cell receptor–engineered T-cell therapy and downloaded from ClinicalTrials.gov updated by June 11, 2018. Informative features and trends were observed in these clinical trials. The number of trials initiated each year is increasing as expected, but an interesting pattern is observed. NY-ESO-1, as the most targeted antigen type, is the target of 31 clinical trials; melanoma is the most targeted cancer type and is the target of 33 clinical trials. Novel antigens and underrepresented cancers remain to be targeted in future studies and clinical trials. Unlike chimeric antigen receptor T-cell therapy, only about 16% of the 84 clinical trials target against hematological malignancies, consistent with T-cell receptor–engineered T-cell therapy’s high potential for solid tumors. Six pharma/biotech companies with novel T-cell receptor–engineered T-cell ideas and products were examined in this review. Multiple approaches have been utilized in these companies to increase the T-cell receptor’s affinity and efficiency and to minimize cross-reactivity. The major challenges in the development of the T-cell receptor–engineered T-cell therapy due to tumor microenvironment were also discussed here." @default.
- W2916895208 created "2019-03-02" @default.
- W2916895208 creator A5083595341 @default.
- W2916895208 creator A5089390131 @default.
- W2916895208 date "2019-01-01" @default.
- W2916895208 modified "2023-10-15" @default.
- W2916895208 title "The Emerging World of TCR-T Cell Trials Against Cancer: A Systematic Review" @default.
- W2916895208 cites W1487671238 @default.
- W2916895208 cites W1548452743 @default.
- W2916895208 cites W1784734551 @default.
- W2916895208 cites W1893566975 @default.
- W2916895208 cites W1898024522 @default.
- W2916895208 cites W1898345095 @default.
- W2916895208 cites W1975653912 @default.
- W2916895208 cites W1983143892 @default.
- W2916895208 cites W1983517349 @default.
- W2916895208 cites W1984060239 @default.
- W2916895208 cites W1993302198 @default.
- W2916895208 cites W1999084855 @default.
- W2916895208 cites W2000121076 @default.
- W2916895208 cites W2000294386 @default.
- W2916895208 cites W2003311353 @default.
- W2916895208 cites W2007753570 @default.
- W2916895208 cites W2008494452 @default.
- W2916895208 cites W2012034410 @default.
- W2916895208 cites W2014751400 @default.
- W2916895208 cites W2015905380 @default.
- W2916895208 cites W2020424124 @default.
- W2916895208 cites W2022394909 @default.
- W2916895208 cites W2032616158 @default.
- W2916895208 cites W2045955301 @default.
- W2916895208 cites W2050302632 @default.
- W2916895208 cites W2054035764 @default.
- W2916895208 cites W2057687465 @default.
- W2916895208 cites W2060910588 @default.
- W2916895208 cites W2061513889 @default.
- W2916895208 cites W2062106696 @default.
- W2916895208 cites W2066671159 @default.
- W2916895208 cites W2068890283 @default.
- W2916895208 cites W2070748533 @default.
- W2916895208 cites W2074325678 @default.
- W2916895208 cites W2075574520 @default.
- W2916895208 cites W2076823120 @default.
- W2916895208 cites W2077301497 @default.
- W2916895208 cites W2092585728 @default.
- W2916895208 cites W2094366129 @default.
- W2916895208 cites W2107408397 @default.
- W2916895208 cites W2107752337 @default.
- W2916895208 cites W2109347785 @default.
- W2916895208 cites W2116582697 @default.
- W2916895208 cites W2116646376 @default.
- W2916895208 cites W2117795738 @default.
- W2916895208 cites W2118471749 @default.
- W2916895208 cites W2122465970 @default.
- W2916895208 cites W2127712120 @default.
- W2916895208 cites W2129623370 @default.
- W2916895208 cites W2130185552 @default.
- W2916895208 cites W2132826139 @default.
- W2916895208 cites W2136100686 @default.
- W2916895208 cites W2138155367 @default.
- W2916895208 cites W2138165178 @default.
- W2916895208 cites W2138494474 @default.
- W2916895208 cites W2142066580 @default.
- W2916895208 cites W2142934889 @default.
- W2916895208 cites W2148334703 @default.
- W2916895208 cites W2150817618 @default.
- W2916895208 cites W2152190417 @default.
- W2916895208 cites W2155323589 @default.
- W2916895208 cites W2156106286 @default.
- W2916895208 cites W2157939496 @default.
- W2916895208 cites W2162222767 @default.
- W2916895208 cites W2165658132 @default.
- W2916895208 cites W2166213184 @default.
- W2916895208 cites W2217081146 @default.
- W2916895208 cites W2290520196 @default.
- W2916895208 cites W2297008886 @default.
- W2916895208 cites W2336636899 @default.
- W2916895208 cites W2340862784 @default.
- W2916895208 cites W2398597901 @default.
- W2916895208 cites W2406954244 @default.
- W2916895208 cites W2407797794 @default.
- W2916895208 cites W2408931491 @default.
- W2916895208 cites W2560367415 @default.
- W2916895208 cites W2562658803 @default.
- W2916895208 cites W2571606850 @default.
- W2916895208 cites W2579404031 @default.
- W2916895208 cites W2596760231 @default.
- W2916895208 cites W2597129987 @default.
- W2916895208 cites W2603665089 @default.
- W2916895208 cites W2617786820 @default.
- W2916895208 cites W2688905162 @default.
- W2916895208 cites W2735536328 @default.
- W2916895208 cites W2747016053 @default.
- W2916895208 cites W2774983464 @default.
- W2916895208 cites W2778172184 @default.
- W2916895208 cites W2781525129 @default.
- W2916895208 cites W2791865738 @default.
- W2916895208 cites W2792949765 @default.